These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21223498)

  • 1. Can neuropathic screening tools be used as outcome measures?
    Searle RD; Bennett MI; Tennant A
    Pain Med; 2011 Feb; 12(2):276-81. PubMed ID: 21223498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain.
    Walsh J; Rabey MI; Hall TM
    J Manipulative Physiol Ther; 2012; 35(3):196-202. PubMed ID: 22397741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
    Bennett MI; Smith BH; Torrance N; Potter J
    J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire.
    Koc R; Erdemoglu AK
    Pain Med; 2010 Jul; 11(7):1107-14. PubMed ID: 20456071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the S-LANSS in the community setting.
    Weingarten TN; Watson JC; Hooten WM; Wollan PC; Melton LJ; Locketz AJ; Wong GY; Yawn BP
    Pain; 2007 Nov; 132(1-2):189-94. PubMed ID: 17869424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brazilian Portuguese validation of the Leeds Assessment of Neuropathic Symptoms and Signs for patients with chronic pain.
    Schestatsky P; Félix-Torres V; Chaves ML; Câmara-Ehlers B; Mucenic T; Caumo W; Nascimento O; Bennett MI
    Pain Med; 2011 Oct; 12(10):1544-50. PubMed ID: 21883875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.
    Batistaki C; Lyrakos G; Drachtidi K; Stamatiou G; Kitsou MC; Kostopanagiotou G
    Pain Pract; 2016 Jun; 16(5):552-64. PubMed ID: 25880345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population.
    Hamdan A; Luna JD; Del Pozo E; Gálvez R
    Eur J Pain; 2014 Jan; 18(1):101-9. PubMed ID: 23776139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Leeds Assessment of Neuropathic Symptoms and Signs Scale (LANSS) is not an adequate outcome measure of pressure ulcer-related neuropathic pain.
    Rutherford C; Nixon JE; Brown JM; Briggs M; Horton M
    Eur J Pain; 2016 Nov; 20(10):1710-1720. PubMed ID: 27172978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation and linguistic validation of the self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) scale for use in a Libyan population.
    Elzahaf RA; Tashani OA; Unsworth BA; Johnson MI
    Pain Pract; 2013 Mar; 13(3):198-205. PubMed ID: 22726274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community.
    Smith BH; Torrance N; Bennett MI; Lee AJ
    Clin J Pain; 2007 Feb; 23(2):143-9. PubMed ID: 17237663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational study.
    Hans G; Masquelier E; De Cock P
    BMC Public Health; 2007 Jul; 7():170. PubMed ID: 17650299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of neuropathic pain: can we use the screening tools?
    Bennett MI; Bouhassira D
    Pain; 2007 Nov; 132(1-2):12-3. PubMed ID: 17888575
    [No Abstract]   [Full Text] [Related]  

  • 14. Pain phenotype in patients with knee osteoarthritis: classification and measurement properties of painDETECT and self-report Leeds assessment of neuropathic symptoms and signs scale in a cross-sectional study.
    Moreton BJ; Tew V; das Nair R; Wheeler M; Walsh DA; Lincoln NB
    Arthritis Care Res (Hoboken); 2015 Apr; 67(4):519-28. PubMed ID: 25155472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
    Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
    J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Screening Tool for Surgery-Specific Neuropathic Pain: Neuropathic Pain Scale for Postsurgical Patients.
    Mejdahl MK; Christoffersens KB; Andersen KG
    Pain Physician; 2019 Mar; 22(2):E81-E90. PubMed ID: 30921980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the Japanese Version of the Leeds Assessment of the Neuropathic Symptoms and Signs Pain Scale: Diagnostic Utility in a Clinical Setting.
    Isomura T; Sumitani M; Matsudaira K; Kawaguchi M; Inoue R; Hozumi J; Tanaka T; Oshima H; Mori K; Taketomi S; Inui H; Tahara K; Yamagami R; Hayakawa K
    Pain Pract; 2017 Jul; 17(6):800-807. PubMed ID: 27770598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic neuropathic pain in the hospital setting: use of screening tools.
    Sadler A; Wilson J; Colvin L
    Clin J Pain; 2013 Jun; 29(6):507-11. PubMed ID: 23247003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Self -Complete of Leeds Assessment Neuropathic Symptoms and Signs: an attempt to adapt it for Polish population].
    Cnotliwy M; Jurewicz A; Gołąb -Janowska M; Kazimierczak A; Głazek W
    Pomeranian J Life Sci; 2016; 62(2):18-21. PubMed ID: 29537216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.
    Walker SM; Peters J; Verriotis M; Farag F; Jay MA; Howard RF
    J Pain; 2024 Feb; 25(2):451-465. PubMed ID: 37741521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.